The Fibroadenoma Market is projected to reach USD 1,093.6 Million by 2030 at 6.5% CAGR during the forecast period 2022-2030. Fibroadenoma is a common benign breast tumor that predominantly affects women, especially those in their reproductive years. While not usually life-threatening, fibroadenomas can cause discomfort and anxiety, prompting individuals to seek effective treatments and...